Amorfix Life Sciences Ltd Stock (AMF.TO)

Amorfix Life Sciences Ltd Stock Price

Latest Press Releases regarding Amorfix Life Sciences Ltd

Company description

Amorfix Life Sciences Ltd logo Amorfix Life Sciences Ltd. is a product development company focused on therapeutic antibodies and diagnostics for the diagnosis and treatment of misfolded protein diseases including amyotrophic lateral sclerosis (ALS), cancer and Alzheimer’s disease (AD). The Company is developing diagnostic products with the goal of detecting the presence of aggregated misfolded proteins (AMPs) in tissue, blood or other biofluids. The Company’s technologies are also being used to develop antibody and vaccine therapies that target disease specific epitopes (DSEs) on disease-relevant proteins as an approach to treat these incurable disorders. The Company’s therapeutics is designed to target and neutralize only the misfolded conformation of a given protein. The Company provides Diagnostic Services using its sensitive and specific Diagnostic Kits to Alzheimer's researchers and prion removal equipment manufacturers.

Visit company website

People involved

Fullname Position
William Wyman Chairman of the Board
Robert Gundel President, Chief Executive Officer, Director, IR Contact Officer
Neil Cashman Chief Scientific Officer, Director
Warren Whitehead Chief Financial Officer, Director
Elliot Goldstein Director